Puer Weiye Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Puer Weiye General Information

Description

Manufacturer of radionuclide-drug conjugates focused on innovative and high-barrier radiological diagnostic and therapeutic drugs.

Contact Information

Website
www.pvbio.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 1-5, 2F
  • Number 6 Hangfeng Road, Fengtai District
  • Beijing, 100070
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • 1-5, 2F
  • Number 6 Hangfeng Road, Fengtai District
  • Beijing, 100070
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Puer Weiye Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Puer Weiye‘s full profile, request access.

Request a free trial

Puer Weiye Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Puer Weiye‘s full profile, request access.

Request a free trial

Puer Weiye FAQs

  • When was Puer Weiye founded?

    Puer Weiye was founded in 2004.

  • Where is Puer Weiye headquartered?

    Puer Weiye is headquartered in Beijing, China.

  • What industry is Puer Weiye in?

    Puer Weiye’s primary industry is Drug Discovery.

  • Is Puer Weiye a private or public company?

    Puer Weiye is a Private company.

  • What is the current valuation of Puer Weiye?

    The current valuation of Puer Weiye is .

  • What is Puer Weiye’s current revenue?

    The current revenue for Puer Weiye is .

  • Who are Puer Weiye’s investors?

    Beijing Yuansen Kangtai Pharmaceutical Research has invested in Puer Weiye.

  • When was Puer Weiye acquired?

    Puer Weiye was acquired on 21-Jun-2021.

  • Who acquired Puer Weiye?

    Puer Weiye was acquired by Grand Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process